Vassilis L Souliotis

19PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma.

|Jun 26, 2026
Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy.

|Mar 14, 2026
ATR Blockade Potentiates the Effects of Genotoxic Agents In Vitro and Promotes Antitumor Immunity in a Mouse Model of Non-Small Cell Lung Cancer.

Dimitra Mavroeidi, Christina Papanikolaou, Elisavet Deligianni

|Oct 29, 2025
DNA Damage Response and Redox Status in the Resistance of Multiple Myeloma Cells to Genotoxic Treatment.

Panagiotis Malamos, Christina Papanikolaou, Elisavet Deligianni

|Jun 26, 2025
Elucidating DNA Damage-Dependent Immune System Activation.

Elisavet Deligianni, Christina Papanikolaou, Evangelos Terpos

|May 23, 2025
Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma.

Christina Papanikolaou, Panagiota Economopoulou, Aris Spathis

Pageof 4

Frequent Collaborators

6 joint publications

Evangelos Terpos

5 joint publications

Panagiotis Malamos

3 joint publications

Meletios A Dimopoulos

3 joint publications

Konstantinos Koutoulogenis